Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HealthStream (HSTM)

HealthStream grants special RSU awards to top executives, including CFO Scott Roberts

Neutral Impact 2 of 5 shareholder Written later

HealthStream's Compensation Committee approved special grants of time-based and performance-based restricted share units to its named executive officers on September 18, 2026, under its shareholder-approved 2022 Omnibus Incentive Plan. The grants are meant to encourage future performance and retention, and they add to the equity compensation of these officers.

Key points

  • Four named executive officers (Robert A. Frist, Jr., Michael M. Collier, Trisha L. Coady, Kevin P. O'Hara) each received 15,395 time-based RSUs with a grant date fair value of $450,000, plus 5,132 performance-based RSUs valued at $150,000 e
  • Scott A. Roberts received 12,316 time-based RSUs valued at $360,000 and 4,105 performance-based RSUs valued at $120,000.
  • Time-based RSUs vest in equal annual 25% installments over four years from the grant date.
  • Performance-based RSUs vest in 25% increments tied to annual targets for 2027 through 2030, to be set by the Committee.

The filing

CompanyHealthStream (HSTM)
Form8-K, current report
Filed with the SECSep 23, 2026, 4:15 PM ET
Accession number0001437749-26-031062

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.